Metis Global Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,329
Closed -$706K 762
2023
Q3
$706K Sell
3,329
-799
-19% -$160K 0.03% 458
2023
Q2
$794K Buy
4,128
+1,182
+40% +$235K 0.04% 414
2023
Q1
$596K Buy
2,946
+1,363
+86% +$219K 0.04% 441
2022
Q4
$203K Buy
+1,583
New +$204K 0.02% 594
2022
Q3
Sell
-1,170
Closed -$207K 555
2022
Q2
$207K Buy
+1,170
New +$169K 0.03% 511

Other funds holding SGEN

Metis Global Partners's SGEN Position: Q4 2023 in Review

Metis Global Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 3,329 shares — an estimated $706K sold.

Metis Global Partners first reported a position in SGEN in Q2 2022 and held it in 5 quarters. The position peaked at $794K in Q2 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Metis Global Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Metis Global Partners sold 3,329 Seagen Inc. Common Stock shares in Q4 2023, an estimated $706K.
  • Metis Global Partners first reported a position in Seagen Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Metis Global Partners's Seagen Inc. Common Stock position peaked at $794K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Metis Global Partners's 13F filing for Q4 2023, filed 6 Feb 2024.